GLP-1 agonists enhance insulin secretion and suppress glucagon release only when blood glucose levels are elevated, a glucose-dependent mechanism that substantially reduces the risk of hypoglycaemia compared to other diabetes medications such as sulphonylureas
Although intensive glycemic control reduces risk, it does not eliminate progression entirely
With meals: take with carbohydrates to maximize cellular uptake (insulin helps absorption)
Of note, different reports have also documented the limited efficacy of similar doses of metformin in terms of improvement of metabolic profiles in experimental models of diabetes in female rats 56,57 , as well as in PNA mice 58 , suggesting that the metabolic effects of metformin may be heterogeneous and inconsistent depending on the dose and preclinical model used
The tertiary structure of the enzyme is stabilized by an extensive network of salt bridges, hydrogen bonds and van der Waals interactions (Thoma et al., 2003)
Several study authors also noted a decrease in body weight and improvements in metabolic factors, such as blood sugar, a valuable outcome, given that individuals with BED and BN often struggle with obesity and/or diabetes
